Session » Abstracts: Osteoarthritis – Clinical
- 9:00AM-10:30AM
-
Abstract Number: 1639
A Phase 3, 56-Week, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial (OA-11) to Evaluate the Efficacy and Safety of a Single Injection of Lorecivivint Injected in the Target Knee Joint of Moderate to Severe Osteoarthritis Participants
- 9:00AM-10:30AM
-
Abstract Number: 1641
Determination and Characterization of Patient Subgroups with Different Pain Progression in Hand Osteoarthritis
- 9:00AM-10:30AM
-
Abstract Number: 1644
Effect of a Lifestyle Program Based on a Whole Food Plant-based Diet, Physical Activity, and Stress Management in Patients with Metabolic Syndrome-Associated Osteoarthritis: A Randomized Controlled Trial
- 9:00AM-10:30AM
-
Abstract Number: 1642
Mast Cells May Explain Sex Differences in Osteoarthritis Pain
- 9:00AM-10:30AM
-
Abstract Number: 1640
Tryptophan Metabolites Are Associated with Erosion and Symptoms in Hand Osteoarthritis: Results from the DIGICOD Cohort
- 9:00AM-10:30AM
-
Abstract Number: 1643
Use of Oral Analgesics and Risk of Comorbidities in Osteoarthritis: Findings from Primary Care Settings in the UK